Invasive lobular carcinoma (ILC) is the second most common histologic type of breast cancer with a proportion of about 5–10%,22 which is believed to have unique clinical and pathological features compared with IDC, for instance, more common in older age, lower expression of HER2, and tending to be HR‐positive.23 The gene discussed is ERBB2; the disease is breast cancer.